The global bone densitometers market is expected to reach USD 1.2 billion by 2025, according to a new study by Grand View Research, Inc. The growing prevalence of metabolic bone diseases is believed to be responsible for the high clinical urgency to adopt bone densitometers, thereby impelling the market demand. Growing base of geriatric and obese population, which is highly susceptible to developing disorders such as osteoporosis, is anticipated to propel the demand further. The aforementioned factors are slated to present the market with lucrative growth opportunities over the coming years.
Browse the report: http://www.orbisresearch.com/reports/index/bone-densitometers-market-analysis-by-technology-axial-bone-densitometry-dexa-qct-peripheral-bone-densitometry-sexa-pdexa-ra-qus-pqct-by-end-use-hospitals-clinics-and-segment-forecasts-2014-2025
Moreover, presence of consistent number of health initiatives to promote awareness pertaining to osteoporosis is anticipated to broaden market growth potential over the coming years. For instance, National Osteoporosis Foundation (NOF), a government healthcare organization that conducts National Bone Health Alliance and Fracture Liaison Service (FLS) care coordination programs, is focused on elevating awareness levels pertaining to available diagnostic & treatment alternatives for osteoporosis. It also encourages training of healthcare professionals for efficient management of osteoporosis.
In addition, advent of technologically advanced devices, such as portable densitometers, is presumed to fuel their adoption in home healthcare. Other technological advancements include implementation of advanced hip assessment software into DXA systems that enabled noninvasive assessment of proximal femur structural geometry. Additional associated benefits include depiction of wide array of parameters such as skeletal mapping, hip axis length assessment, areal BMD determination, and cross-sectional area & the femoral strength index.
Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/267639
Further Key Findings From the Study Suggest:
Peripheral bone densitometry is expected to exhibit lucrative CAGR owing to increasing adoption in wide array of clinical applications. The high penetration can be attributed to efficient peripheral fracture risk assessment, not achievable by other technologies.
Clinics are anticipated to exhibit lucrative CAGR during the forecast period owing to advent of portable densitometers that are increasingly being preferred by clinicians due to associated benefits such as compact size, accuracy, and ease of transportation.
In 2016, North America held a dominant share of the global bone densitometers market, as a consequence of increasing localized presence of prominent companies undertaking competitive sustainability strategies.
Asia Pacific is anticipated to grow at an exponential CAGR due to unmet patient needs, continuous technological & infrastructural upgradation, and growing healthcare expenditure.
Some key participants implement various competitive strategies, such as new product development & frequent product approvals, to maintain their position in the market.
For instance, in October 2016, BeamMed launched neonatal bone growth assessment software for premature babies, which is compatible with most of the densitometer tools.
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019